The study by Fagnan et al. also found a subset of AEL cases (n = 10, or 30.4% of their cohort) with a significantly lower mutational burden, having less mutations per sample on average than TP53-mutated or epigenetic regulator subgroups. Here, TP53 is linked to acute erythroid leukemia.